Related Experiment Video

Updated: Sep 8, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K

Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks

Zhimin Yang1,2, Tang Liu1,2, Xiaolei Ren1,2

  • 1Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Hunan, China.

Cell Cycle (Georgetown, Tex.)
|June 14, 2022
PubMed

Insights

MicroRNA-34a (miR-34a) is downregulated in osteosarcoma (OS), impacting cancer cell growth and survival. Further research into miR-34a mechanisms could yield new diagnostic and therapeutic strategies for this aggressive bone cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Osteosarcoma (OS) is a highly aggressive bone malignancy with unsatisfactory survival rates despite standard treatments.
  • Decreased expression of microRNA-34a (miR-34a) has been observed in OS, suggesting its role in the disease.
  • miR-34a regulates multiple genes post-transcriptionally and influences key cellular processes.

Purpose of the Study:

  • To review the relationship between miR-34a and osteosarcoma.
  • To elucidate the specific mechanisms by which miR-34a influences OS development.
  • To present the potential of miR-34a as a diagnostic, prognostic, and therapeutic candidate for OS.

Main Methods:

  • Literature review summarizing existing studies on miR-34a and osteosarcoma.
  • Analysis of molecular mechanisms involving miR-34a in OS cell proliferation, differentiation, migration, and apoptosis.
  • Evaluation of miR-34a's potential as a biomarker.

Main Results:

  • miR-34a plays a critical role in mediating OS cell proliferation, differentiation, migration, and apoptosis.
  • Downregulation of miR-34a is implicated in osteosarcoma development.
  • miR-34a shows potential as a pivotal biomarker for OS.

Conclusions:

  • miR-34a is a significant factor in osteosarcoma pathogenesis.
  • miR-34a holds promise as a diagnostic, prognostic, and therapeutic target for osteosarcoma.
  • Further investigation is required to fully understand the molecular mechanisms of miR-34a in OS.
Keywords:
MiR-34adiagnosisosteosarcomaprognosestreatment

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K